MIZUHO MEDY CO.,LTD.

4595

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-12FY2026 Q2

Revenue

108.2100M JPY

YoY +0.7%

Operating Income

10100M JPY

YoY -32.5%

Net Income

32.3100M JPY

YoY -2.3%

EPS

43.2JPY

YoY -19.4%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

175.8億円

131.9億円

87.9億円

44億円

Rev: 131.4億円Op: 67億円NI: 48.2億円

Rev: 175.8億円Op: 111億円NI: 78.4億円

Rev: 109.9億円Op: 51.5億円NI: 37.7億円

Rev: 114.3億円Op: 49.2億円NI: 37.7億円

Rev: 112.6億円Op: 46.5億円NI: 34.3億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income-

Revenue Progress35.300M

Revenue Forecast114.300M

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan